BAUSCH HEALTH COS INC's ticker is BHC and the CUSIP is 071734107. A total of 352 filers reported holding BAUSCH HEALTH COS INC in Q1 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,546,096 | +9.2% | 1,526,289 | +4.0% | 0.01% | 0.0% |
Q2 2023 | $11,486,500 | +179967.4% | 1,466,986 | +77.3% | 0.01% | +30.0% |
Q1 2023 | $6,379 | -4.4% | 827,440 | -22.1% | 0.01% | 0.0% |
Q4 2022 | $6,672 | -99.9% | 1,062,357 | -24.8% | 0.01% | -33.3% |
Q3 2022 | $9,818,000 | -40.2% | 1,412,602 | +99.3% | 0.02% | -28.6% |
Q1 2022 | $16,421,000 | -65.2% | 708,694 | -57.7% | 0.02% | -61.1% |
Q3 2021 | $47,198,000 | +99.5% | 1,677,275 | +120.0% | 0.05% | +50.0% |
Q1 2021 | $23,663,000 | +162.8% | 762,326 | +69.8% | 0.04% | +176.9% |
Q4 2020 | $9,004,000 | +1.4% | 448,842 | -24.8% | 0.01% | -40.9% |
Q3 2020 | $8,882,000 | +60.6% | 596,857 | +96.3% | 0.02% | +46.7% |
Q2 2020 | $5,531,000 | -0.2% | 304,100 | -16.3% | 0.02% | -11.8% |
Q1 2020 | $5,541,000 | -30.3% | 363,300 | -0.8% | 0.02% | -22.7% |
Q3 2019 | $7,950,000 | -44.0% | 366,371 | -34.9% | 0.02% | -45.0% |
Q2 2019 | $14,195,000 | +21.3% | 562,882 | +18.8% | 0.04% | +17.6% |
Q1 2019 | $11,702,000 | +37.3% | 473,722 | +4.4% | 0.03% | +41.7% |
Q4 2018 | $8,526,000 | -47.5% | 453,738 | -28.3% | 0.02% | -33.3% |
Q3 2018 | $16,241,000 | – | 632,713 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paulson & Co. | 26,439,035 | $211,512,280 | 20.65% |
GoldenTree Asset Management | 20,056,228 | $160,449,824 | 14.55% |
Chou Associates Management | 715,000 | $5,719,997 | 7.24% |
HIGHLAND PEAK CAPITAL, LLC | 1,002,674 | $8,021,392 | 3.54% |
Finepoint Capital LP | 1,165,000 | $9,320,000 | 3.22% |
Icahn Capital | 34,721,118 | $277,769 | 1.79% |
MFN Partners Management, LP | 6,000,000 | $48,000,000 | 1.56% |
Kohlberg Kravis Roberts & Co. L.P. | 5,235,000 | $41,880,000 | 1.30% |
Lombard Odier Asset Management (USA) Corp | 6,200,000 | $49,600,000 | 1.05% |
Segantii Capital Management Ltd | 2,500,000 | $20,000,000 | 1.04% |